Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 3/30/2026 | $13.00 | Mkt Outperform | Citizens | |
| 3/27/2026 | $18.00 | Buy | B. Riley Securities | |
| 3/12/2026 | $11.00 | Outperform | Oppenheimer | |
| 3/6/2026 | $1.50 | Equal Weight → Underweight | Barclays | |
| 2/19/2026 | $8.30 | Reduce → Hold | HSBC Securities | |
| 2/5/2026 | $3.00 | Neutral → Buy | Seaport Research Partners | |
| 2/4/2026 | Buy → Hold | Maxim Group | ||
| 1/15/2026 | $1.50 | Equal-Weight → Underweight | Morgan Stanley |
For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons
For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of
For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO
144 - QuantumScape Corp (0001811414) (Subject)
10-K - Blink Charging Co. (0001429764) (Filer)
10-K - Allbirds, Inc. (0001653909) (Filer)
SAN FRANCISCO, March 30, 2026 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ:BIRD) today announced that it has entered into a definitive agreement with American Exchange Group ("AXNY"), a leader in accessories design, licensing and manufacturing, under which AXNY will acquire all of the intellectual property and certain other assets and liabilities of Allbirds for an estimated transaction value of $39 million (the "Asset Sale"), subject to purchase price adjustments to be finalized upon closing. The Asset Sale was negotiated by a special committee of independent directors, received unanimous approval by Allbirds' Board of Directors, and is subject to approval by Allbirds' common stockholders.
Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi
Execution of disciplined operational strategy, strengthened revenue quality, and focused DC fast charging investment continues driving Blink's long term scalable growth. Bowie, MD, March 26, 2026 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ:BLNK) ("Blink" or the "Company"), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced financial results for the fourth quarter, and full year, ended on December 31, 2025. FOURTH QUARTER HIGHTLIGHTS Fourth quarter 2025 total revenues were $27.0 million. Full year 2025 total revenues were $103.5 million.Fourth quarter 2025 service revenues grew 62.0% year-over-year (YOY) to $14.7 m
4 - Blink Charging Co. (0001429764) (Issuer)
4 - Blink Charging Co. (0001429764) (Issuer)
4 - Blink Charging Co. (0001429764) (Issuer)
4 - QuantumScape Corp (0001811414) (Issuer)
4 - QuantumScape Corp (0001811414) (Issuer)
4 - QuantumScape Corp (0001811414) (Issuer)
Citizens initiated coverage of fuboTV with a rating of Mkt Outperform and set a new price target of $13.00
B. Riley Securities initiated coverage of fuboTV with a rating of Buy and set a new price target of $18.00
Oppenheimer initiated coverage of Prime Medicine with a rating of Outperform and set a new price target of $11.00
Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical OfficerDr. Walker will continue advancing Novavax's R&D efforts with a focus on data generation to facilitate partnering discussions, Matrix adjuvant innovation and advancement of the Company pipeline GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr. Walker now reports to John C. Jacobs, President and Chief Executive Officer of Novavax.A specialist in internal medicine and pulmonary and critical care medi
WINSTON-SALEM, N.C., March 25, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp. (NASDAQ:PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cell therapy company focused on chronic kidney disease (CKD), today announced the appointment of Greg Madison as Chief Commercial Officer. In this role, Mr. Madison will drive ProKidney's commercial strategy as the Company advances towards the potential commercialization of rilparencel. "Greg is a seasoned commercial biopharma executive with a proven track record of building high-performing organizations, shaping strategy, and preparing innovative therapies for market," said Bruce Culleton, M.D., CEO of ProKidney. "He brings valuable operation
QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced the appointment of Ross Niebergall to its board of directors. Niebergall is an experienced executive with decades of service in the defense sector, leading R&D and technology commercialization in defense applications for multiple defense primes. Niebergall was most recently President of Aerojet Rocketdyne after its acquisition by L3Harris. He was Chief Technology Officer of L3Harris and Harris Corporation from 2017 to 2023. Previous to Harris Corporation, he was Vice President, Engineering at Raytheon and served as CEO of ThalesRaytheon Systems LLC, a join
SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)
SC 13D/A - Prime Medicine, Inc. (0001894562) (Subject)
SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)
SAN FRANCISCO, March 30, 2026 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ:BIRD) today announced that it has entered into a definitive agreement with American Exchange Group ("AXNY"), a leader in accessories design, licensing and manufacturing, under which AXNY will acquire all of the intellectual property and certain other assets and liabilities of Allbirds for an estimated transaction value of $39 million (the "Asset Sale"), subject to purchase price adjustments to be finalized upon closing. The Asset Sale was negotiated by a special committee of independent directors, received unanimous approval by Allbirds' Board of Directors, and is subject to approval by Allbirds' common stockholders.
Bowie, MD, March 19, 2026 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ:BLNK) ("Blink" or the "Company"), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, will announce its fourth quarter and full year 2025 results on Thursday, March 26, 2026, following the close of the financial markets. The Company will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the Company's results ended on December 31, 2025. To access the live webcast, log onto the Blink Charging website at http://blinkcharging.com/, and click on the News/Events section of the Investor Relations page. Investors may also access the webcast v
SAN FRANCISCO, March 10, 2026 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ:BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today announced that its fourth quarter and full year 2025 financial results will be released after market close on Tuesday, March 31, 2026. The company will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. A live webcast of the conference call will be available on the Allbirds investor relations website at https://ir.allbirds.com. A replay will be made available online and archived for 12 months on the investor relations website following
